Journal for ImmunoTherapy of Cancer, 2024
Immune cell topography of head and neck cancer

Muijlwijk T., Nijenhuis D., Ganzevles S. et al.

Diabetes Research and Clinical Practice, 2024
Proteomics profiling and association with cardiorenal complications in type 2 diabetes subtypes in Asian population

Gurung R., Zheng H., Lee B. et al.

Heliyon, 2024
Causal relationships between immune cells, inflammatory factors, serum metabolites, and hepatic cancer: A two-sample Mendelian randomization study

Chen H., Yang R., Zhang J. et al.

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024
Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms

Villikudathil A., Mc Guigan D., English A.

Nature Communications, 2024
Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants

Shetty N., Gaonkar M., Patel N. et al.

Diabetes Care, 2024
Large-Scale Proteomics Improve Prediction of Chronic Kidney Disease in People With Diabetes

Ye Z., Zhang Y., Zhang Y. et al.

The Journal of Headache and Pain, 2024
Elevated cytokine levels in the central nervous system of cluster headache patients in bout and in remission

Ran C., Olofsgård F., Wellfelt K. et al.

ESC Heart Failure, 2024
Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Qayyum A., Frljak S., Juhl M. et al.

Nature Medicine, 2024
Proteomic signatures improve risk prediction for common and rare diseases

Carrasco-Zanini J., Pietzner M., Davitte J. et al.

Cytokine, 2024
Circulating inflammatory proteins and abdominal aortic aneurysm: A two-sample Mendelian randomization and colocalization analyses

Chen Z., Chen T., Lin R. et al.

ESC Heart Failure, 2024
IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure

Baumhove L., van Essen B., Dokter M. et al.

Journal of Proteome Research, 2024
Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression

Yu S., Yang L., Shu J. et al.

Archives of Dermatological Research, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo

Yamaguchi Y., Peeva E., Duca E. et al.

JHEP Reports, 2024
Inflammation in liver fibrosis and atrial fibrillation: a prospective population-based proteomic study

Boeckmans J., Michel M., Gieswinkel A. et al.

Diabetes, Obesity and Metabolism, 2024
The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study

Zhang Y., Chen B., Yang Q. et al.

Journal of Affective Disorders, 2024
Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity

Sun D., Wang R., Du Q. et al.

eBioMedicine, 2024
Sustained chronic inflammation and altered childhood vaccine responses in children exposed to Zika virus

Foo S., Chen W., Azamor T. et al.

Nature, 2024
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan

Widjaja A., Lim W., Viswanathan S. et al.

Clinical Cancer Research, 2024
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

Reinmuth N., Juan-Vidal O., Kowalski D. et al.

Clinical Kidney Journal, 2024
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up

Dupont V., Xhaard C., Behm-Ansmant I. et al.